Sputum completion and conversion rates after intensive phase of tuberculosis treatment: an assessment of the Rwandan control program
- PMID: 22800438
- PMCID: PMC3413528
- DOI: 10.1186/1756-0500-5-357
Sputum completion and conversion rates after intensive phase of tuberculosis treatment: an assessment of the Rwandan control program
Abstract
Background: In Rwanda tuberculosis (TB) is one of the major health problems. To contribute to an improved performance of the Rwandan National TB Control Program, we conducted a study with the following objectives: (1) to assess the completion rate of sputum smear examinations at the end of the intensive phase of TB treatment; (2) to assess the sputum conversion rate (SCR); (3) to assess associations between smear completion rate or SCR with key health facility characteristics.
Methods: TB registers in 89 health facilities in five provinces were reviewed. Data of new and retreatment smear-positive pulmonary TB (PTB+) cases registered between January and June 2006 were included in the study. Data on key characteristics of the selected health facilities were also collected.
Results: Among 1509 new PTB + cases, 32 (2.1%) had died by 2 months, and 178 (11.8%) had been transferred-out. Among the remaining 1299 patients, a smear examination at month 2 was done in 1039 (smear completion rate 80.0%). Among these 1039, 852 (82.0%) had become smear-negative. The smear completion rate and SCR varied considerably between health facilities. A high number of new PTB cases at a health facility was the only significant predictor of a low completion rate, while the only independent factor associated with low sputum conversion rates was rural (vs. urban) location of the health facility.
Conclusions: In Rwanda, too few patients get a smear examination after 2 months of TB treatment; the SCR among those with smear results was adequate at 82%. A high number of new TB patients at a health facility was a significant predictor of a low completion rate. The national TB control program should design strategies to improve completion rates.
Figures

Similar articles
-
Prevalence and factors associated with sputum smear non-conversion after two months of tuberculosis treatment among smear-positive pulmonary tuberculosis patients in Rwanda: a cross-sectional study.BMC Infect Dis. 2023 Jun 15;23(1):408. doi: 10.1186/s12879-023-08395-6. BMC Infect Dis. 2023. PMID: 37322426 Free PMC article.
-
Should sputum smear examination be carried out at the end of the intensive phase and end of treatment in sputum smear negative pulmonary TB patients?PLoS One. 2012;7(11):e49238. doi: 10.1371/journal.pone.0049238. Epub 2012 Nov 9. PLoS One. 2012. PMID: 23152880 Free PMC article.
-
Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.BMC Infect Dis. 2016 Aug 2;16:365. doi: 10.1186/s12879-016-1712-y. BMC Infect Dis. 2016. PMID: 27484399 Free PMC article.
-
Effects of positive deviance nutrition intervention on sputum smear conversion among patients on tuberculosis medication in Kericho County, Kenya.Indian J Tuberc. 2025;72 Suppl 1:S68-S74. doi: 10.1016/j.ijtb.2025.02.006. Epub 2025 Feb 7. Indian J Tuberc. 2025. PMID: 40023547 Review.
-
A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis.Int J Tuberc Lung Dis. 2000 Feb;4(2):97-107. Int J Tuberc Lung Dis. 2000. PMID: 10694086 Review.
Cited by
-
The effects of anti-inflammatory agents as host-directed adjunct treatment of tuberculosis in humans: a systematic review and meta-analysis.Respir Res. 2020 Aug 26;21(1):223. doi: 10.1186/s12931-020-01488-9. Respir Res. 2020. PMID: 32847532 Free PMC article.
-
Disciplining sexual and reproductive behaviour of tuberculosis patients in Bangladesh: a mixed method study exploring divergent messages.Sex Reprod Health Matters. 2021;29(2):1959258. doi: 10.1080/26410397.2021.1959258. Sex Reprod Health Matters. 2021. PMID: 34396920 Free PMC article.
-
Time to Sputum Smear Conversion in Smear-Positive Pulmonary Tuberculosis Patients and Factors for Delayed Conversion.Iran J Med Sci. 2016 Jan;41(1):44-7. Iran J Med Sci. 2016. PMID: 26722144 Free PMC article.
-
Second month sputum smear as a predictor of tuberculosis treatment outcomes in Brazil.BMC Res Notes. 2018 Jun 28;11(1):414. doi: 10.1186/s13104-018-3522-3. BMC Res Notes. 2018. PMID: 29954436 Free PMC article.
-
Changing from single-drug to fixed-dose combinations: experience from Fiji.Public Health Action. 2014 Sep 21;4(3):169-73. doi: 10.5588/pha.14.0024. Public Health Action. 2014. PMID: 26400805 Free PMC article.
References
-
- World Health Organization. Global Tuberculosis Control 2011. WHO report 2011. WHO, Geneva; 2011. WHO/HTM/TB/2011.16.
-
- World Health Organization. TB/HIV Clinical manual. WHO, Geneva; 2004. WHO/HTM/TB/2004.329.
-
- Rwanda Biomedical Center (RBC). Institute of HIV/AIDS, Disease Prevention & Control (IHDPC) TB & Other Respiratory Communicable Diseases Division. Rwanda ministry of Health. Annual report 2010. RBC/RMOH, Kigali; 2010.
-
- World Health Organization. Treatment of tuberculosis guidelines. WHO, Geneva; 2010. WHO/HTM/TB/2009.420. - PubMed
-
- World Health Organization. Compendium of indicators for Monitoring and Evaluating National Tuberculosis programs. WHO, Geneva; 2004. WHO/HTM/TB/2004.344.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources